Zaptra 25 mg/0.25 mg Capsule
- Manufacturer : Intas Pharmaceuticals Ltd.
- Composition : Paroxetine 25mg, Clonazepam 0.25mg
- Generally Prescribed For : Depression, Obsessive Compulsive Disorder, Anxiety Disorder, Premenstrual Dysphoric Disorder
- Estimated Price : ₹197.00 For 10 capsules / strip
BUY FROM THESE SELLERS
Uses of Zaptra 25 mg/0.25 mg CapsuleZaptra 25 mg/0.25 mg Capsule is used for the treatment or prevention of the following disease(s):
Depression, Obsessive Compulsive Disorder, Anxiety Disorder, Premenstrual Dysphoric Disorder
Side effects of Zaptra 25 mg/0.25 mg CapsuleThe most common side effects of Zaptra 25 mg/0.25 mg Capsule are - Fever, Headache, Insomnia, Sleep Disturbance, Chest Pain, Abdominal Pain, Constipation, Diarrhea,Nausea, Vomiting
These side effects can usually occur in patients. However, these are only indicative and not all patients will experience them.
Precautions while using Zaptra 25 mg/0.25 mg CapsuleDo not use Zaptra 25 mg/0.25 mg Capsule if you are allergic to - Paroxetine, Clonazepam
If you have heart disease, liver or kidney disease, drug or alcohol addiction, consult your doctor before using Zaptra 25 mg/0.25 mg Capsule.
If you are allergic to any medicine or food, consult your doctor before using this medicine.
Use this medicine under the supervision of your doctor.
To avoid an adverse reaction, consult your doctor if you are already taking other medicines.
How Zaptra 25 mg/0.25 mg Capsule worksZaptra 25 mg/0.25 mg Capsule contains - Paroxetine, Clonazepam
Paroxetine works by preventing the reuptake of one neurotransmitter, serotonin, by nerve cells after it has been released.
Clonazepam prevents seizures by potentiating the effects of gamma-aminobutyric acid GABA, which is an inhibitory neurotransmitter. Suppresses the spread of seizure activity caused by seizure-producing foci in the cortex, thalamus, and limbic structures.
Dosage of Zaptra 25 mg/0.25 mg CapsuleThe dosage of Zaptra 25 mg/0.25 mg Capsule depends on many factors such as the patient age, health, medical condition or history of the patient and many other conditions.
Please use this medicine as prescribed by your doctor.
Overdose of Zaptra 25 mg/0.25 mg CapsuleIf you forget to take a dose of Zaptra 25 mg/0.25 mg Capsule, do not take two doses at the same time, there is a risk of overdose.
If you notice any unusual reaction in your body after taking this medicine, contact your doctor immediately or call your local medical emergency number.
Precautions & Warnings
InteractionDrug :- antacids: Hastened release of C.R. paroxetine aspirin, NSAIDs, warfarin: Increased anticoagulant activity and risk of bleeding.
astemizole: Increased risk of arrhythmias.
atomoxetine, risperidone, other drugs metabolized by CYP2D6, such as amitriptyline, desipramine, fluoxetine, imipramine, phenothiazines, tamoxifen, type IC antiarrhythmics: Increased plasma levels of these drugs.
barbiturates, primidone: Decreased blood paroxetine level.
cimetidine: Possibly increased blood paroxetine level.
cisapride, isoniazid, MAO inhibitors, procarbazine: Possibly serotonin syndrome.
codeine, haloperidol, metoprolol, perphenazine, propranolol, risperidone, thioridazine: Decreased metabolism and increased effects of these drugs.
cyproheptadine: Decreased paroxetine effects.
dextromethorphan: Decreased dextromethorphan metabolism and increased risk of toxicity.
digoxin: Possibly decreased digoxin effects.
encainide, flecainide, propafenone, quinidine: Potentiated toxicity of these drugs.
fosamprenavir, ritonavir: Decreased plasma paroxetine level.
lithium: Possibly increased blood paroxetine level, increased risk of serotonin syndrome.
methadone: Decreased methadone metabolism, increased risk of adverse effects.
phenytoin: Possibly phenytoin toxicity.
pimozide: Increased risk of prolonged QT interval.
procyclidine: Increased blood procyclidine level and anticholinergic effects.
serotonergic drugs such as linezolid, St. John's wort, tramadol, triptans, and tryptophan: Increased risk of serotonin syndrome.
tamoxifen: Decreased tamoxifen effectiveness.
theophylline: Possibly increased blood theophylline level and risk of toxicity.
thioridazine: Increased thioridazine level, possibly leading to prolonged QT interval and life-threatening ventricular arrhythmias.
tramadol: Increased risk of serotonin syndrome and seizures.
tricyclic antidepressants: Increased metabolism and blood antidepressant levels, increased risk of toxicity, including seizures.